Evidence map›Paper›PMID 34922770›Full record

ArticleGynecologic oncology2022

Promoting timely goals of care conversations between gynecologic cancer patients at high-risk of death and their providers.

Brittany A Davidson, Allison M Puechl, Catherine H Watson, Stephanie Lim, Luke Gatta, Karen Monuszko, Kerry Drury, Emma S Ryan, Shelley Rice, Tracy Truong and 5 more

Open access · greenAbstract read
In one paragraph

Article in Gynecologic oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Trends in hospice referral timing and location among individuals dying of ovarian cancer: persistence of missed opportunities.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Brittany A DavidsonDivision of Gynecologic Oncology, Duke Cancer Institute, Durham, NC 27710, United States of America; Duke Cancer Institute, Durham, NC 27710, United States of America. Electronic address: Brittany.davidson@duke.edu.
Allison M PuechlDivision of Gynecologic Oncology, Duke Cancer Institute, Durham, NC 27710, United States of America.
Catherine H WatsonDivision of Gynecologic Oncology, Duke Cancer Institute, Durham, NC 27710, United States of America.
Stephanie LimDepartment of Obstetrics & Gynecology, Duke University, Durham, NC 27710, United States of America.
Luke GattaDepartment of Obstetrics & Gynecology, Duke University, Durham, NC 27710, United States of America.
Karen MonuszkoDuke University Medical School, Durham, NC 27710, United States of America.
Kerry DruryDepartment of Obstetrics & Gynecology, Duke University, Durham, NC 27710, United States of America.
Emma S RyanDuke University Medical School, Durham, NC 27710, United States of America.
Shelley RiceDivision of Palliative Care, Duke University Health System, Durham, NC 27710, United States of America.
Tracy TruongDepartment of Biostatistics & Bioinformatics, Duke University, Durham, NC 27710, United States of America.
Jessica MaDurham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham VA Health Care System, Durham, NC 27705, United States of America.
Steve PowerOffice of the Chief Medical Officer, Duke University Health System, Durham, NC 27710, United States of America.
Weston JordanOffice of the Chief Medical Officer, Duke University Health System, Durham, NC 27710, United States of America.
Kelli KurtovicDepartment of Obstetrics & Gynecology, Duke University, Durham, NC 27710, United States of America.
Laura J HavrileskyDivision of Gynecologic Oncology, Duke Cancer Institute, Durham, NC 27710, United States of America; Duke Cancer Institute, Durham, NC 27710, United States of America.
Duke University · USDuke Cancer InstituteDuke University Health System · USDuke Medical Center · USDurham VA Health Care System · US

Funding

Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
NCATS NIH HHS UL1 TR002553
6 · The paper itself

Abstract

objectiveWe designed a multi-faceted intervention to increase the rate of outpatient goals of care (GOC) conversations in women with gynecologic cancers who are at high-risk of death. METHODS AND MATERIALS: A multidisciplinary team developed an educational program around GOC conversations at end-of-life and chose criteria to prospectively identify patients at high-risk of death who might benefit from timely GOC conversations: recurrent or metastatic endometrial, cervical or vulvar cancer or platinum-resistant ovarian cancer. Gynecologic oncology provider consensus was built regarding the need to improve the quality and timing of GOC conversations. Eligible outpatients were prospectively identified and providers alerted pre-encounter; timely GOC documentation within 3 visits of high-risk identification was tracked. Our institution concurrently and subsequently tracked GOC documentation during the last 6 months of life among all established oncology patients.

resultsOf 220 pilot period high-risk patients (96 pre- and 124 during pilot period 2017-2018), timely GOC discussion documentation increased from 30.2% to 88.7% (p < 0.001) and this increase was sustained over time. In the post-pilot period (2019-2020), among patients seen by oncologists during last 6 months of life, compared to other cancer types, gynecologic cancer patients had a higher rate of GOC documentation (81% versus 9%; p < 0.001), a lower rate of receiving chemotherapy during the last 14 days of life (2% vs 5%; p = 0.051), and no difference in end-of-life admissions (29% vs 31%; p = NS).

conclusionsImplementation of systematic outpatient identification of high-risk gynecologic oncology patients is feasible, sustainable, and increases the timely conduct of GOC conversations.

Indexed as

Advance Care PlanningPatient Care PlanningRisk AssessmentAgedAmbulatory CareCommunicationFemaleGenital Neoplasms, FemaleHumansMiddle AgedPhysician-Patient RelationsPilot ProjectsTerminal CareTime FactorsWorkflowGoals of careGynecologic cancerQuality

Identifiers

PMID34922770
PMCPMC8799508
OpenAlexW4200170560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.